Literature DB >> 12077038

Drug points: Severe myalgia from an interaction between treatments with pantoprazole and methotrexate.

U Tröger1, B Stötzel, J Martens-Lobenhoffer, H Gollnick, F P Meyer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12077038      PMCID： PMC116448          DOI： 10.1136/bmj.324.7352.1497

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

Review 1.  Methotrexate in rheumatoid arthritis: an update with focus on mechanisms involved in toxicity.

Authors:  A E van Ede; R F Laan; H J Blom; R A De Abreu; L B van de Putte
Journal:  Semin Arthritis Rheum       Date:  1998-04       Impact factor: 5.532

Review 2.  The remarkable spectrum of methotrexate toxicities.

Authors:  R J McKendry
Journal:  Rheum Dis Clin North Am       Date:  1997-11       Impact factor: 2.670

3.  Underrecognized postdosing reactions to methotrexate in patients with rheumatoid arthritis.

Authors:  J T Halla; J G Hardin
Journal:  J Rheumatol       Date:  1994-07       Impact factor: 4.666

4.  Trace analysis of methotrexate and 7-hydroxymethotrexate in human plasma and urine by a novel high-performance liquid chromatographic method.

Authors:  O Beck; P Seideman; M Wennberg; C Peterson
Journal:  Ther Drug Monit       Date:  1991-11       Impact factor: 3.681

5.  Interruption of long-term methotrexate treatment in psoriasis. Evaluation of clinical course and laboratory parameters after discontinuation and reintroduction of weekly oral methotrexate.

Authors:  R J van Dooren-Greebe; A L Kuijpers; F Termorshuizen; P C van de Kerkhof
Journal:  Acta Derm Venereol       Date:  1995-09       Impact factor: 4.437
  5 in total
  11 in total

1.  Potential drug-drug interactions between anti-cancer agents and community pharmacy dispensed drugs.

Authors:  Marsha L Voll; Kim D Yap; Wim E Terpstra; Mirjam Crul
Journal:  Pharm World Sci       Date:  2010-07-20

Review 2.  Pharmacokinetic drug interaction profiles of proton pump inhibitors.

Authors:  Henning Blume; Frank Donath; André Warnke; Barbara S Schug
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 3.  Accumulating evidence for a drug-drug interaction between methotrexate and proton pump inhibitors.

Authors:  Shewit Bezabeh; Ann Corken Mackey; Paul Kluetz; Dilara Jappar; Joyce Korvick
Journal:  Oncologist       Date:  2012-04-03

4.  Role of the breast cancer resistance protein (ABCG2) in drug transport.

Authors:  Qingcheng Mao; Jashvant D Unadkat
Journal:  AAPS J       Date:  2005-05-11       Impact factor: 4.009

Review 5.  Effect of proton pump inhibitors on high-dose methotrexate elimination: a systematic review and meta-analysis.

Authors:  Xi Wang; Yanqin Song; Jingjing Wang; Jin He; Ruming Liu; Xiaosu Li; Hua Huang; Jun Zhang
Journal:  Int J Clin Pharm       Date:  2020-01-08

6.  Determinants of the elimination of methotrexate and 7-hydroxy-methotrexate following high-dose infusional therapy to cancer patients.

Authors:  M Joerger; A D R Huitema; H J G D van den Bongard; P Baas; J H Schornagel; J H M Schellens; J H Beijnen
Journal:  Br J Clin Pharmacol       Date:  2006-07       Impact factor: 4.335

Review 7.  Clinical pharmacology of proton pump inhibitors: what the practising physician needs to know.

Authors:  Malcolm Robinson; John Horn
Journal:  Drugs       Date:  2003       Impact factor: 9.546

8.  Retrospective evaluation of methotrexate elimination when co-administered with proton pump inhibitors.

Authors:  David J Reeves; Elizabeth S Moore; Devon Bascom; Brandon Rensing
Journal:  Br J Clin Pharmacol       Date:  2014-09       Impact factor: 4.335

Review 9.  Proton Pump Inhibitors and Oncologic Treatment Efficacy: A Practical Review of the Literature for Oncologists.

Authors:  Angel A T Uchiyama; Pedro A I A Silva; Moisés S M Lopes; Cheng T Yen; Eliza D Ricardo; Taciana Mutão; Jefferson R Pimenta; Larissa M Machado; Denis S Shimba; Renata D Peixoto
Journal:  Curr Oncol       Date:  2021-02-03       Impact factor: 3.677

10.  Consensus Guideline for Use of Glucarpidase in Patients with High-Dose Methotrexate Induced Acute Kidney Injury and Delayed Methotrexate Clearance.

Authors:  Laura B Ramsey; Frank M Balis; Maureen M O'Brien; Kjeld Schmiegelow; Jennifer L Pauley; Archie Bleyer; Brigitte C Widemann; David Askenazi; Sharon Bergeron; Anushree Shirali; Stefan Schwartz; Alexander A Vinks; Jesper Heldrup
Journal:  Oncologist       Date:  2017-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.